KYMR Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Kymera Therapeutics Inc

Watchlist Manager

Watchlist

Price: 107.43 USD -2.44% Market Closed

Market Cap: $8.8B

	Kymera Therapeutics Inc NASDAQ:KYMR	US
	East West Bancorp Inc NASDAQ:EWBC	US
E	Equinix Inc SWB:EQN2	US
	JG Summit Holdings Inc OTC:JGSMY	PH
	Rhythm Pharmaceuticals Inc NASDAQ:RYTM	US
J	JG Summit Holdings Inc XPHS:JGS	PH
N	Nike Inc SWB:NKE	US

Profitability Summary

Kymera Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-334%

Negative 3Y Average Operating Margin

-469%

Operating Margin is Increasing

-395% > -334%

Negative Net Margin

-285%

Negative 3Y Average Net Margin

-415%

Net Margin is Increasing

-357% > -285%

Negative Free Cash Flow Margin

-227%

Negative 3Y Average Free Cash Flow Margin

-357%

Free Cash Flow Margin is Increasing

-371% > -227%

Negative ROE

-24%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-69%

ROIC is Increasing

-109% > -50%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.